SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
130.20    2.40 (1.88%)
Bid:
130.00
Ask:
130.40
Spread: 0.40 (0.308%)
Market Cap: £268.15m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Board Changes

10 Dec 2019 07:00

RNS Number : 2749W
Forterra plc
10 December 2019
 

10 December 2019

 

Forterra plc

Board Changes

 

Forterra plc ("Forterra" or the "Company") announces that Shatish Dasani is stepping down from his role as Chief Financial Officer and as a Director of the Board on 31 December 2019 to pursue other opportunities. Forterra also announces that Ben Guyatt will be appointed as Chief Financial Officer on 1 January 2020 and will join the Board of Forterra at that point.

 

Shatish Dasani joined Forterra in December 2015 and was a key member of the leadership team which successfully took the Company through the IPO in April 2016 and implemented the strategy to drive value for shareholders. In his time with Forterra, he has overseen a significant deleveraging and strengthening of its balance sheet, whilst investing in the core businesses and following a progressive dividend policy.

 

Ben Guyatt has served as Director of Finance and Company Secretary of Forterra since its listing in April 2016 and, prior to this, he was Finance Director of the business at the time of its divestment by HeidelbergCement in 2015. Ben joined Hanson plc in 2006 and held a variety of senior finance and strategy roles within Hanson and HeidelbergCement. Previously Ben held financial management roles at Heath Lambert. The Board believes that Ben will bring a deep and valuable knowledge of Forterra, and the wider market, to the Board.

 

Justin Atkinson, Chairman, commented:

 

"On behalf of the Board I would like to thank Shatish for his substantial contribution to the Company over the last four years and wish him well in the next stage of his career.

 

"I am delighted that Ben will be joining the Board as Chief Financial Officer. Having worked with Ben since the successful IPO, I am convinced he will bring significant knowledge and experience to the Board."

 

Shatish Dasani commented:

 

"I have enjoyed tremendously my time at Forterra and would like to thank the Board and all members of staff for their support. I leave the Group in a strong financial and strategic position, with great potential to continue delivering value for all stakeholders. After four years with the Group, I believe that this is the right time for me to pursue other career opportunities. I wish the team well as they take the business on the next stage of its development."

 

 

Enquiries

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain

Nick Hasell

 

 

The Company confirms that there are no other disclosures to be made in connection with Ben Guyatt's appointment under LR 9.6.13R of the Listing Rules.

 

Shatish Dasani's leaving arrangements have been determined in accordance with our Directors' Remuneration Policy. The statement required by s.430 (2B) of the Companies Act 2006 will be made available for shareholders on the Company's website as soon as reasonably practicable following the date on which Mr Dasani ceases to be a Director.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAVKLFBKLFEFBX
Date   Source Headline
11th Jun 20262:52 pmRNSGrant under Long Term Incentive Plan
11th Jun 20267:00 amRNSDirectorate change
9th Jun 202611:53 amRNSHolding(s) in Company
9th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20269:45 amRNSTransaction in Own Shares
2nd Jun 202612:32 pmRNSEmployee Benefit Trust Share Purchase
2nd Jun 202612:30 pmRNSTotal Voting Rights and Capital
1st Jun 20267:00 amRNSAppointment of New Independent NED
27th May 20267:00 amRNSTransaction in Own Shares
21st May 20265:03 pmRNSHolding(s) in Company
19th May 20264:41 pmRNSAnnual General Meeting 2026 Results
19th May 20267:01 amRNSTransaction in Own Shares
19th May 20267:00 amRNSAGM Trading Update
12th May 20261:32 pmRNSTransaction in Own Shares
12th May 20267:00 amRNSAGM RESOLUTION – APPROVAL OF REMUNERATION POLICY
7th May 20261:43 pmRNSHolding(s) in Company
6th May 202610:50 amRNSTransaction in Own Shares
6th May 20269:58 amRNSTotal Voting Rights and Capital
6th May 20269:55 amRNSEmployee Benefit Trust Share Purchase
28th Apr 202610:20 amRNSHolding(s) in Company
28th Apr 202610:18 amRNSTransaction in Own Shares
21st Apr 202611:31 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSEmployee Benefit Trust Share Purchase
15th Apr 20265:40 pmRNSNotice of Annual General Meeting 2026
14th Apr 202610:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSAppointment of new Independent NED
9th Apr 202610:15 amRNSHolding(s) in Company
9th Apr 20267:00 amRNSDirector Declaration
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20262:07 pmRNSTotal Voting Rights
7th Apr 202612:47 pmRNSEmployee Benefit Trust Share Purchase
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20261:03 pmRNSDirector / PCA Shareholdings
25th Mar 202610:50 amRNSAnnual Report and Accounts 2025
24th Mar 202610:40 amRNSTransaction in Own Shares
24th Mar 20269:01 amRNSHolding(s) in Company
24th Mar 20267:00 amRNSReplacement:Grant under Deferred Annual Bonus Plan
20th Mar 20268:45 amRNSGrant under Deferred Annual Bonus Plan
17th Mar 20267:00 amRNSEmployee Benefit Trust Share Purchase
17th Mar 20267:00 amRNSEmployee Benefit Trust Share Purchase
16th Mar 202610:32 amRNSLaunch of £20m Share Buyback Programme
16th Mar 202610:32 amRNSLaunch of £20m Share Buyback Programme
11th Mar 20267:00 amRNSFull Year Results
3rd Mar 20263:27 pmRNSEmployee Benefit Trust Share Purchase
18th Feb 20262:27 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 202612:26 pmRNSEmployee Benefit Trust Share Purchase
29th Jan 20268:33 amRNSHolding(s) in Company
28th Jan 20269:21 amRNSHolding(s) in Company
26th Jan 20264:07 pmRNSHolding(s) in Company
22nd Jan 20267:00 amRNSFull Year 2025 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.